Letters to the Editor

Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms

Volume 58 · Issue 4 · June 2026 Publish Date: June 16, 2026
Full Text PDF
DOI
Yuji Kan ORCID
Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan
Hisashi Uhara ORCID
Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan
Kan, Y., & Uhara, H. (2026). Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms. The Eurasian Journal of Medicine, 58(4), 1–2. https://doi.org/10.5152/eurasianjmed.2026.261426
Full Text Full Text PDF

Abstract

-

Similar Articles

Article Info
Published In
Journal The Eurasian Journal of Medicine
Volume / Issue Volume 58 · Issue 4 · June 2026
Pages 1-2
History
Published Online June 16, 2026
License
Affiliations
Yuji Kan ORCID
Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan
Hisashi Uhara ORCID
Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan
Cite this Article
Kan, Y., & Uhara, H. (2026). Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms. The Eurasian Journal of Medicine, 58(4), 1–2. https://doi.org/10.5152/eurasianjmed.2026.261426
Share
Outlines